Manufacturers of intermittent pneumatic compression devices designed for prevention of deep vein thromboses can probably start looking for a new indication for their gadgets. A study conducted by physicians from the Walter Reed Army Medical Center has demonstrated that pneumatic compression devices (PCDs) can be used as a treatment option for people with restless legs syndrome. The research was published in the journal Chest.
Results of the study from the abstract:
Thirty-five subjects were enrolled. Groups were similar at baseline. Therapeutic PCDs significantly improved all measured variables more than shams. Restless Legs Severity Score improved from 14.1 ± 3.9 to 8.4 ± 3.4 (p = 0.006) and Johns Hopkins Restless Legs Scale improved from 2.2 ± 0.5 to 1.2 ± 0.7 (p = 0.01). All quality of life domains improved more with therapeutic than sham devices (social function 14% vs 1%, respectively; p = 0.03; daytime function 21% vs 6%, respectively, p = 0.02; sleep quality 16% vs 8%, respectively, p = 0.05; emotional well-being 17% vs 10%, respectively, p = 0.15). Both Epworth sleepiness scale (6.5 ± 4.0 vs 11.3 ± 3.9, respectively, p = 0.04) and fatigue (4.1 ± 2.1 vs 6.9 ± 2.0, respectively, p = 0.01) improved more with therapeutic devices than sham devices. Complete relief occurred in one third of subjects using therapeutic and in no subjects using sham devices.
Abstract in Chest January 2009 vol. 135 no. 1 74-80
Image: malik ml williams